Crescent Biopharma, Inc. (CBIO) stock
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.04−0.46 (-3.41%)
Close on Nov 17, 2026Market cap $484.36MP/E –Yield –
Crescent Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Crescent Biopharma's market cap was $409.54M on Nov 11, 2026, against $209.08M a year earlier. Over the last 5 years it ranged from $21.39M to $19.32B, with a median of $2.64B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $409.54M | +148.6% |
| 2025 | Dec 31, 2025 | $164.77M | -89.8% |
| 2024 | Dec 31, 2024 | $1.61B | -89.4% |
| 2023 | Dec 29, 2023 | $15.19B | -4.4% |
| 2022 | Dec 30, 2022 | $15.88B | +113.2% |
| 2021 | Dec 31, 2021 | $7.45B | -58.6% |
| 2020 | Dec 31, 2020 | $17.98B | -21.6% |
| 2019 | Dec 31, 2019 | $22.94B | -43.9% |
| 2018 | Dec 31, 2018 | $40.85B | -25.7% |
| 2017 | Dec 29, 2017 | $54.97B | +290.7% |
| 2016 | Dec 30, 2016 | $14.07B | +29.2% |
| 2015 | Dec 31, 2015 | $10.89B | -20.0% |
| 2014 | Dec 31, 2014 | $13.60B | – |
See a number that looks wrong?